News
MoonLake Immunotherapeutics to host a Capital Markets Day on Tuesday, April 29 Zug, Switzerland, April 25, 2025 - MoonLake Immunotherapeutics (Nasdaq: MLTX), a clinical-stage biotechnology company ...
MoonLake Immunotherapeutics to host a Capital Markets Day on Tuesday, April 29 ...
Studies involving multiple aspects of plaque psoriasis evolution, persistence, and progression have produced clues and ...
Substantial savings opportunities exist by using lower-cost biologics for patients with plaque psoriasis, according to one ...
After falling 17 per cent since the start of the year to its March lows, the stock of the country's largest pharmaceutical ...
Organon Canada, a global healthcare company with a mission to improve the health of women throughout their lives, today announced that Health Canada has approved NDUVRA (tapinarof cream), 1%, the ...
Johnson & Johnson (J&J) has reported data from the Phase III ICONIC-LEAD trial’s subgroup analysis evaluating icotrokinra in treating moderate-to-severe plaque psoriasis (PsO). The data revealed ...
The trial aims to assess the therapy’s safety and efficacy in treating moderate-to-severe plaque psoriasis. Credit: Fuss Sergey/Shutterstock. Johnson & Johnson (J&J) has reported data from the Phase ...
Accessed April 2025. 6 Clinicaltrials.gov. A study of JNJ-2113 for the treatment of participants with plaque psoriasis involving special areas (scalp, genital, and/or palms of the hands and the soles ...
Icotrokinra achieved 75% complete skin clearance in adolescents with moderate to severe plaque psoriasis by week 24, indicating significant efficacy. The ICONIC-LEAD trial is the first to evaluate ...
But your toes might be sending important messages about your cardiovascular health long before other symptoms appear. Those cold, discolored, or uncomfortable toes aren’t just an inconvenience.
A spoof "blue plaque" has gone on display in Knaresborough to commemorate actor Danny Dyer's visit to the market town. The Eastenders star delighted residents when he showed up to shoot a Sky ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results